4 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Oral P2Y12 inhibitors ... Switching P2Y12 ... Intravenous (Cangrelor ... ) and Oral P2Y12 ... Among Oral P2Y12
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... Oral P2Y12 Inhibitors ... CIRCULATIONAHA.117.031164 #P2Y12 ... Clopidogrel #plavix #antiplatelet ... ticagrelor #prasugrel #pharmacology
Antiplatelet Conversion - P2Y12 Inhibitor Switching
 • Clopidogrel (Plavix)
 • Prasugrel (Effient)
 • Ticagrelor (Brilinta)
Clopidogrel and
Antiplatelet Conversion ... Switching • Clopidogrel ... @accpcardprn #Antiplatelet ... #Inhibitor #Switching ... #pharmacology #
Cangrelor - Pharmacology
Cangrelor (Kengreal) is a parenteral analogue of adenosine triphosphate
Cangrelor binds reversibly to the platelet
Cangrelor - Pharmacology ... pre-treated with an oral ... No oral/enteral ... CABG) - As antiplatelet ... from IV to PO Antiplatelet